Status:

UNKNOWN

Efficacy of Intra-articular Injection of Human Amniotic Suspension Allograft and Platelet-rich Plasma in the Treatment of Knee Osteoarthritis.

Lead Sponsor:

Kaohsiung Veterans General Hospital.

Conditions:

Knee Osteoarthristis

Eligibility:

All Genders

20-80 years

Phase:

NA

Brief Summary

A double-blind, randomized controlled trial designed to evaluate the symptomatic modulating efficacy of amniotic suspension allograft (ASA) in comparison to platelet-rich plasma (PRP), hyaluronic acid...

Detailed Description

At least 150 subjects with osteoarthritic knee will be recruited and computer randomized 1:1:1:1 to single injection of ASA (40mg), ASA (20mg), PRP + HA, and NS groups. Both subjects and evaluaters we...

Eligibility Criteria

Inclusion

  • Age between 20 and 80 years
  • Ability to provide informed consent
  • Unilateral or bilateral knee VAS pain score ≥ 4 of 10 (worst possible pain) for more than 4 months
  • Diagnosis of OA Kellgren-Lawrence I-III by radiography (triple-film of bilateral lower limb, standard knee anterior-posterior view in full extension, lateral view in 30-degrees flexion, and 45°Merchant views)
  • No prior PRP injection of knee
  • No prior surgical procedure of the participating knee
  • BMI\<40 kg/m2

Exclusion

  • Lawrence stage IV
  • Major axial deviation (varus\> 5°, valgus \> 5°)
  • Any concomitant symptomatic knee disorder (i.e. ligamentous/ meniscal injury)
  • Systemic inflammatory arthropathy
  • Hematologic diseases
  • Severe cardiovascular disease
  • Neurological disorders
  • Active infection
  • Immuno-compromised
  • Therapy with anticoagulants or antiaggregants
  • Use of NSAIDs and/or chondroprotective supplements, such as glucosamines and chondroitin sulfates, within 7 days prior to trial
  • Recent intra-articular injection of corticosteroids (within 30 days)
  • Prior treatment with HA in past 6 monthsHb\< 11 g/dL
  • Platelet count \< 150,000/mm3

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2023

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04698265

Start Date

January 1 2021

End Date

January 31 2023

Last Update

January 6 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.